Cannabis for Obesity Trial
Part of paid clinical trials in Lexington, Kentucky.
- Sponsor
- Joshua A. Lile, Ph.D.
- Study ID
- NCT06137365
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Cannabis — DRUGCannabis gummy product will be prepared using cannabis flower extract.
- Placebo — DRUGPlacebo gummy product will be prepared using the same ingredients as the cannabis gummy but will not contain active cannabinoids.
Study Details
The goal of this study is to determine the initial efficacy of once daily oral cannabis for weight loss in obese individuals.
Key Dates
- First listed
- Nov 18, 2023
- Start date
- Aug 5, 2026
- Status verified
- Aug 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ActiveCannabis "gummy", starting at 5 mg THC and increased every three weeks by 5 mg increments up to a maximum target dose of 15 mg THC, administered once daily for duration of 6-month trial participation.
- Placebo Comparator: PlaceboPlacebo cannabis "gummy", containing no active THC, administered once daily for duration of 6-month trial participation.
Primary Outcome Measure
Weight change [ Time Frame: weekly for duration of 6-month trial ]
Central Contacts
- Joshua Lile8593236034
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40517 |
Find similar trials in Lexington, KY
By condition
By specialty
By research site
Related Studies
- Adrenergic Cholinergic Enteric Measures/MappingRecruiting · University of Louisville · Louisville, Kentucky
- The Effects of Mirabegron and Tadalafil on Glucose Tolerance in PrediabeticsPHASE4 · Recruiting · Philip Kern · Lexington, Kentucky
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightPHASE2 · Recruiting · Eli Lilly and Company · Chandler, Arizona
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)PHASE3 · Recruiting · Eli Lilly and Company · Tucson, Arizona